CBD Knee Osteoarthritis Study
Part of paid clinical trials in Memphis, Tennessee.
- Sponsor
- University of Tennessee
- Study ID
- NCT07638189
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Osteoarthitis
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cannabidiol (CBD) — DIETARY_SUPPLEMENT250 mg of CBD will be dissolved in 1 ml of Castor Oil. Participants will use 1ml of this solution on each knee BID
- Castor Oil (Placebo) — OTHER1 ml of Castor oil alone will be applied to each knee BID as the placebo
Study Details
Osteoarthritis of the knee is a common cause of pain in the US. The currently available medicines for knee osteoarthritis sometimes are not effective at relieving the pain or have unacceptable side effects. Thus, alternate pain relieving treatments are needed. CBD, an active chemical from the hemp derived cannabis sativa plant, has received a lot of attention for its potential pain relieving properties, but there has been limited research to find out if topically applied CBD can decrease pain from knee osteoarthritis. CBD lacks the psychoactive effects seen with marijuana use, because it does not contain THC which is responsible for those effects in marijuana. It is legal to use CBD in the State of Tennessee (site of study). The CBD Knee Study is sponsored by the University of Tennessee Health Science Center and is a collaborative effort between doctors at UT and Campbell Clinic. In the CBD Knee Study, the investigators are examining whether topically applied CBD dissolved in Castor Oil will relieve knee pain in persons with knee osteoarthritis. Persons who take part in the study would need to come for study visits, fill out questionnaires about their health and knee pain, and would be asked to use the topical study oil on their knees. Taking part in the CBD Knee Study is voluntary.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 20, 2028
- Completion
- Mar 30, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: CBD+Castol Oil250 mg CBD dissolved in 1 ml of Castor Oil to be applied topically to the knee BID
- Placebo Comparator: Castor Oil Alone1 ml of Castor Oil Alone applied topically to the knee as the placebo comparator BID
Primary Outcome Measure
Knee Pain [ Time Frame: Day 1 - Baseline One Visit, Day 30 - Follow-up One Visit, Day 44 - Baseline Two Visit, and Day 74 - Follow-up Two Visit ]
Central Contacts
- Karen Derefinko, PhD901-448-5900
- William Mihalko, MD, PhD901-448-2666
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Tennessee Health Science Center | Memphis | Tennessee | 38163 | Karen C Johnson, MD, MPH (PRINCIPAL_INVESTIGATOR) Karen Derefinko, PhD (PRINCIPAL_INVESTIGATOR) William Mihalko, MD, PhD (SUB_INVESTIGATOR) Phyllis Richey, PhD (SUB_INVESTIGATOR) Fridtjof Thomas, PhD (SUB_INVESTIGATOR) |